Clinical benefit and risk of elemene in cancer patients undergoing chemotherapy: a systematic review and meta-analysis.

导出 LinkOut

翻译打印收藏纠错

第一作者： Yanhong,Pan

第一单位： Department of Pharmacy, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.

作者： Yanhong,Pan ^[1] ; Panting,Wan ^[2] ; Li,Zhang ^[1] ; Cuirong,Wang ^[1] ; Yijun,Wang ^[1]

作者单位： Department of Pharmacy, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China. ^[1] Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China. ^[2]

关键词 cancer patients chemotherapy efficacy elemene side effects variables

DOI 10.3389/fphar.2023.1185987

PMID 37601061

发布时间 2023-08-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in pharmacology

2023年14卷

1185987页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Clinical benefit and risk of elemene in cancer patients undergoing chemotherapy: a systematic review and meta-analysis.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Clinical benefit and risk of elemene in cancer patients undergoing chemotherapy: a systematic review and meta-analysis.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

检索历史清除